AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Ondansetron USP
5 registrations across 3 African markets— 3 active
Markets with Ondansetron USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| EMITINO Tablets | 🇷🇼Rwanda | CACHET PHARMACEUTIVAL Pvt.LTD | active | Aug 2029 |
| Ofran Injection Injection | 🇰🇪Kenya | SQUARE Pharmaceuticals Ltd. | active | Aug 2028 |
| Ondem-MD 4 Tablet | 🇰🇪Kenya | Alkem Laboratories Limited | active | Dec 2027 |
| ONDANSETRON TABLETS 8MG TABLETS / 10X10 | 🇳🇬Nigeria | CHANRAI HEALTHCARE LTD PLOT 122-132 | expired | Aug 2021 |
| ONDANSETRON TABLETS 4MG TABLETS / 10X10 | 🇳🇬Nigeria | CHANRAI HEALTHCARE LTD PLOT 122-132 | expired | Aug 2021 |
Ondansetron USP in Africa — Regulatory Overview
Ondansetron USP is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Nigeria, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 3 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.